Transcriptomic Analysis and Optical Coherence Tomography Combined for Patients With Basal Cell Carcinoma
NCT ID: NCT06813833
Last Updated: 2025-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
50 participants
OBSERVATIONAL
2025-01-06
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question of the study is to examine if the combination of these two techniques, transcriptomic and OCT, can improve noninvasive detection of human BCCs.
All included patients will undergo 1) an OCT scan and 2) a tape strip collection for transcriptomic analysis from the same BCC.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Diagnostic Accuracy of Advanced Imaging in Identifying Suspected Skin Cancer (Basal Cell Carcinoma) Around the Eyes
NCT06279143
Skin Tumor Biomarkers by Mass Spectrometry Imaging
NCT06227416
Optical Coherence Tomography Guided C&D
NCT04510727
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
NCT05138328
cOCT Versus LC-OCT for Diagnosing Basal Cell Carcinoma: a Diagnostic Cohort Study
NCT06024629
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merete Haedersdal
Professor, Chief Physician, DMSc, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Merete Haedersdal, Professor, MD, DMSc, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Dermatology, Copenhagen University Hospital - Bispebjerg, Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Dermatology, Bispebjerg Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-24060543
Identifier Type: OTHER
Identifier Source: secondary_id
H-24060543
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.